Clinical Trial Update: PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for PEG-rhG-CSF in patients with lymphoma receiving chemotherapy. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• PEG-rhG-G-CSF (pegylated recombinant human granulocyte colony-stimulating factor)

Snippet

Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Conditions: Lymphoma | Phase 4 | Status: COMPLETED